Literature DB >> 27647775

Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study.

Piotr Niewinski1, Dariusz Janczak2, Artur Rucinski2, Stanislaw Tubek1,3, Zoar J Engelman4, Pawel Piesiak5, Przemyslaw Jazwiec6, Waldemar Banasiak1, Marat Fudim7, Paul A Sobotka4,8, Shahrokh Javaheri9,10, Emma C J Hart11, Julian F R Paton11, Piotr Ponikowski1,3.   

Abstract

AIMS: Augmented reflex responses from peripheral chemoreceptors, which are mainly localized in the carotid bodies (CBs), characterize patients with systolic heart failure and contribute to adrenergic hyperactivation. We investigated whether surgical resection of CBs in these patients can be performed safely to decrease sympathetic tone. METHODS AND
RESULTS: We studied 10 male patients with systolic heart failure (age, 59 ± 3 years; LVEF, 27 ± 7%) who underwent unilateral right-sided CB resection (four patients) or bilateral CB resection (six patients). Primary endpoints of the study were changes in muscle sympathetic nerve activity (MSNA) and peripheral chemosensitivity measured as ventilatory response to hypoxia from baseline to 1 month post-CB resection. Safety analysis included analysis of arterial blood gas and oxygenation at night through 2 months post-procedure and adverse events assessed up to 12 months. At the 1-month visit, CB resection was associated with a significant decrease both in MSNA (86.6 ± 3.1 vs. 79.7 ± 4.2 bursts/100 beats, P = 0.03) and in peripheral chemosensitivity (1.35 ± 0.19 vs. 0.41 ± 0.17 L/min/SpO2 , P = 0.005). It also resulted in improved exercise tolerance. Amongst some patients with bilateral CB resection, there was a trend towards worsening of oxygen saturation at night, which in one case required therapy with non-invasive ventilation.
CONCLUSION: We present first-in-man evidence that CB resection in patients with systolic heart failure is associated with a decrease in sympathetic activity. A bilateral procedure may carry a risk of worsening oxygenation at night. CB modulation constitutes an interesting research avenue, but careful consideration of the balance between safety and efficacy is necessary before further clinical trials.
© 2016 The Authors. European Journal of Heart Failure © 2016 European Society of Cardiology.

Entities:  

Keywords:  Carotid body; Heart failure; Sympathetic modulation

Mesh:

Year:  2016        PMID: 27647775     DOI: 10.1002/ejhf.641

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  26 in total

1.  Carotid chemoreflex activity restrains post-exercise cardiac autonomic control in healthy humans and in patients with pulmonary arterial hypertension.

Authors:  Marcelle Paula-Ribeiro; Indyanara C Ribeiro; Liliane C Aranda; Talita M Silva; Camila M Costa; Roberta P Ramos; Jaquelina S Ota-Arakaki; Sergio L Cravo; Luiz E Nery; Michael K Stickland; Bruno M Silva
Journal:  J Physiol       Date:  2019-01-30       Impact factor: 5.182

Review 2.  Revisiting the physiological effects of exercise training on autonomic regulation and chemoreflex control in heart failure: does ejection fraction matter?

Authors:  David C Andrade; Alexis Arce-Alvarez; Camilo Toledo; Hugo S Díaz; Claudia Lucero; Rodrigo A Quintanilla; Harold D Schultz; Noah J Marcus; Markus Amann; Rodrigo Del Rio
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-22       Impact factor: 4.733

Review 3.  Role of the carotid body chemoreceptors in glucose homeostasis and thermoregulation in humans.

Authors:  Michael J Joyner; Jacqueline K Limberg; Erica A Wehrwein; Blair D Johnson
Journal:  J Physiol       Date:  2018-03-05       Impact factor: 5.182

Review 4.  Devices and interventions for the prevention of adverse outcomes of tachycardia on heart failure.

Authors:  Jasneet Devgun; Yash B Jobanputra; Michael Arustamyan; Robert Chait; Waqas Ghumman
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

Review 5.  Update on Chemoreception: Influence on Cardiorespiratory Regulation and Pathophysiology.

Authors:  Jerome A Dempsey; Curtis A Smith
Journal:  Clin Chest Med       Date:  2019-06       Impact factor: 2.878

Review 6.  Carotid Body Ablation: a New Target to Address Central Autonomic Dysfunction.

Authors:  Rodrigo Iturriaga
Journal:  Curr Hypertens Rep       Date:  2018-05-22       Impact factor: 5.369

7.  Ecto-5'-nucleotidase (CD73) regulates peripheral chemoreceptor activity and cardiorespiratory responses to hypoxia.

Authors:  Andrew P Holmes; Clare J Ray; Selina A Pearson; Andrew M Coney; Prem Kumar
Journal:  J Physiol       Date:  2017-07-09       Impact factor: 5.182

Review 8.  Translating carotid body function into clinical medicine.

Authors:  Rodrigo Iturriaga
Journal:  J Physiol       Date:  2017-11-23       Impact factor: 5.182

9.  Variable role of carotid bodies in cardiovascular responses to exercise, hypoxia and hypercapnia in spontaneously hypertensive rats.

Authors:  Wioletta Pijacka; Pedro L Katayama; Helio C Salgado; Gisele S Lincevicius; Ruy R Campos; Fiona D McBryde; Julian F R Paton
Journal:  J Physiol       Date:  2018-02-12       Impact factor: 5.182

Review 10.  Obesity, kidney dysfunction, and inflammation: interactions in hypertension.

Authors:  John E Hall; Alan J Mouton; Alexandre A da Silva; Ana C M Omoto; Zhen Wang; Xuan Li; Jussara M do Carmo
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.